Le Lézard
Classified in: Health, Science and technology
Subject: Personnel

ClexBio Announces New Appointments to Board of Directors


ClexBio, an early-stage biotech company developing next-generation tissue engineered grafts for transplant, is announcing the appointment of two new members to its Board of Directors. Joining the board with immediate effect are Andreas Lehmann as non-executive Chairman and Wasim Malik as independent Director. Armend G. Håti, Co-Founder and CEO of ClexBio, will continue to serve on the Board.

Mr Lehmann brings an extensive track record from in- and outside the healthcare industry both as a manager and an early stage investor and advisor. Most recently he has held executive roles in Global Strategy and Managed Markets at Novartis in Switzerland and the US, prior to that he was a Senior Engagement Manager at McKinsey & Co's pharma & biotech practice and a commercial lawyer advising on M&A and international arbitration across Europe and China. He holds a Master of Law from Universities of Berne and Geneva in Switzerland, and an MBA from INSEAD.

Dr Malik is an industry veteran and thought leader who is currently the Managing Director of Iaso Ventures, a Boston based venture capital firm, and serves on the faculty of Harvard Medical School and Massachusetts General Hospital. He previously was the Chief Digital Strategist at Roivant Sciences and sits on the board of the Epilepsy Foundation in addition to several corporate boards. He received his PhD in electrical engineering from Oxford, postdoctoral training in neuroscience from MIT, and finance education from Harvard Business School.

Welcoming Mr Lehmann as Chairman, Mr Håti noted his close involvement in the company since its founding in early 2020. "Andreas has been instrumental in getting ClexBio to where it is today ? he has been a key enabler of our fundraising rounds to date and a critical architect of our commercial strategy since Day 1. His appointment to the role of chairman is a natural next step in the growth of the company."

On Dr Malik's appointment, both Dr Håti and Mr Lehmann highlighted the unique mix of experiences he brings to the Board. "Wasim has both an in-depth understanding of our science and what it takes to take a medical technology solution to market. His experience as a company builder and investor will help us focus on the right value inflection points as we prepare for our future equity fundraising, refine our business strategy, and continue with product development and validation."

About ClexBio

ClexBio is a pre-clinical stage biotech company developing next-generation tissue-engineered allogeneic grafts for transplant, using its proprietary platform technologies CLEX and VivoSet.

For inquiries, please write to [email protected] or follow ClexBio on LinkedIn. ClexBio is legally registered in Norway as Nordovo Biosciences AS.


These press releases may also interest you

at 11:27
Koji, the world's most powerful Link in Bio platform and the leading app store for social media, today announced the launch of Content Drop App, a new app that allows Creators to schedule and post multimedia content regularly inside their Link in...

at 11:25
In the news release, Electronic Caregiver ranks No. 968 among fastest-growing private companies on the 2022 Inc. 5000 annual list, issued 16-Aug-2022 by Electronic Caregiver over PR Newswire, we are advised by the company that the revenue growth...

at 11:16
Aloe Care Health ("Aloe Care"), makers of the world's most advanced voice-activated medical alert and communication service for eldercare, have released compelling new data about the use of its service relating to caregiver engagement....

at 11:15
Electronic communication archiving company MessageWatcher is excited to announce they have been chosen to join LinkedIn's Compliance Partner Program. The program helps selected businesses leverage trusted technology to assist them with complying...

at 11:15
Verséa Holdings, Inc. ("Verséa"), a Florida-based health care company engaged in commercialization of innovative diagnostics, therapeutics, and health services, welcomes Rob Sambursky, MD, who joined the company as the President, effective as of...

at 11:15
The "Gaming Market by Type and Geography - Forecast and Analysis 2022-2026" report has been added to Technavio's offering. With ISO 9001:2015 certification, Technavio is proudly partnering with more than 100 Fortune 500 companies for over 16...



News published on 1 july 2022 at 11:30 and distributed by: